We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
-7.71%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$2.02B
AUM Growth
-$724M
Cap. Flow
-$220M
Cap. Flow %
-10.91%
Top 10 Hldgs %
39.64%
Holding
568
New
150
Increased
73
Reduced
93
Closed
152

Top Buys

Rank Stock Value
1
AABA
Altaba Inc
AABA
+$137M
2
HSBC icon
HSBC
HSBC
+$104M
3
SMFG icon
Sumitomo Mitsui Financial
SMFG
+$67.2M
4
HDB icon
HDFC Bank
HDB
+$55.9M
5
BABA icon
Alibaba
BABA
+$44.7M

Sector Composition

Rank Sector Weight
1 Financials 28.01%
2 Technology 26.77%
3 Healthcare 9.76%
4 Consumer Discretionary 9.25%
5 Industrials 5.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KODK icon
376
Kodak
KODK
$806M
$48K ﹤0.01%
18,193
VSTM icon
377
Verastem
VSTM
$532M
$47K ﹤0.01%
3,267
CTIC
378
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$46K ﹤0.01%
54,931
ABUS icon
379
Arbutus Biopharma
ABUS
$865M
$44K ﹤0.01%
29,104
KOPN icon
380
Kopin
KOPN
$663M
$43K ﹤0.01%
63,533
FSTX
381
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$40K ﹤0.01%
2,855
ROX
382
DELISTED
Castle Brands, Inc.
ROX
$37K ﹤0.01%
29,234
BFX
383
DELISTED
BowFlex Inc.
BFX
$33K ﹤0.01%
24,125
HSDT icon
384
Solana Company
HSDT
$95.2M
0
VATE icon
385
INNOVATE Corp
VATE
$114M
$32K ﹤0.01%
1,349
VUZI icon
386
Vuzix
VUZI
$190M
$31K ﹤0.01%
13,438
ACGN
387
DELISTED
Aceragen Inc
ACGN
$31K ﹤0.01%
641
JCP
388
DELISTED
J.C. Penney Company, Inc.
JCP
$31K ﹤0.01%
+34,514
New +$29K
KG
389
Kestrel Group
KG
$71.3M
$29K ﹤0.01%
1,944
TRQ
390
DELISTED
Turquoise Hill Resources Ltd
TRQ
$29K ﹤0.01%
6,105
-74,287
-92% -$447K
DF
391
DELISTED
Dean Foods Company
DF
$28K ﹤0.01%
+23,821
New +$28.2K
CLUB
392
DELISTED
Town Sports International Holdings, Inc.
CLUB
$26K ﹤0.01%
15,577
BGFV
393
DELISTED
Big 5 Sporting Goods
BGFV
$24K ﹤0.01%
11,457
SREV
394
DELISTED
ServiceSource International, Inc.
SREV
$22K ﹤0.01%
25,000
NEOS
395
DELISTED
Neos Therapeutics, Inc
NEOS
$22K ﹤0.01%
15,038
IBRX icon
396
ImmunityBio
IBRX
$7.44B
$20K ﹤0.01%
16,092
TBHC
397
DELISTED
The Brand House Collective
TBHC
$19K ﹤0.01%
12,242
LRMR icon
398
Larimar Therapeutics
LRMR
$416M
$19K ﹤0.01%
2,094
RNAC icon
399
Cartesian Therapeutics
RNAC
$232M
$19K ﹤0.01%
362
CWBR
400
DELISTED
CohBar, Inc. Common Stock
CWBR
$18K ﹤0.01%
451

Similar funds

LMR Partners's Q3 2019 Portfolio in Review

As of Q3 2019, LMR Partners held 568 positions worth $2.02B, down 26% from $2.74B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

LMR Partners withdrew a net $220M in Q3 2019, closing 152 positions and reducing 93 holdings. Its most notable exit was Anadarko Petroleum, an estimated $173M position sold in full.

By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.

Against the trend, LMR Partners opened a new position in HSBC worth $103M.

  • LMR Partners's largest Q3 2019 buy was HSBC: 2,675,144 shares worth $103M.
  • LMR Partners added most to Altaba Inc in Q3 2019, an estimated $137M increase.
  • LMR Partners's biggest Q3 2019 reduction was Celgene Corp, cutting an estimated $46M.
  • LMR Partners fully exited Anadarko Petroleum in Q3 2019, selling an estimated $173M.
  • LMR Partners's ten largest holdings make up 40% of its $2.02B portfolio in Q3 2019.
  • LMR Partners opened 150 new positions and closed 152 in Q3 2019.
  • LMR Partners's portfolio value fell 26% quarter-over-quarter to $2.02B.

Based on LMR Partners's 13F filing for Q3 2019, filed 14 Nov 2019.